Cardiac rhythm management (CRM) is a well established segment of the cardiology devices market. CRM devices are commonly used for the treatment of arrhythmias and heart failure. Factors like market demand, innovative products, government regulations and reimbursement policies influence the CRM market. The market is facing slowdown in sales but with technological advancements, such as introduction of MRI pacemakers, subcutaneous ICDs, and home automated external defibrillators (AEDs), it is expected to bounce back. The CRM market is mainly bifurcated into two segments viz. Implantable Cardioverter Defibrillators (ICD) market and Implantable Pacemakers market. For the past several years, pacemakers and ICDs have become a common therapy given to patients suffering from cardiac rhythm abnormalities. ICD is the larger segment of the CRM market in comparison with pacemakers. Sales of both the segments are likely to increase, resulting in the improvement of the overall cardiac rhythm management market. The competition in the global CRM market is intense with few large players viz. Medtronic, Boston Scientific and St. Jude Medical. The key trends observed within the industry including the shifting focus towards primary prevention. On the development front, there has been a launch of new pacemakers as well as significant technological advancements in ICDs. However, the industry remains threatened by certain challenges. The major factors which will contribute in the growth of the industry include growing ageing population since with age people get more heart diseases, rising obese population, increasing cases of hypertension as high blood pressure is a major risk for heart attack and rising healthcare expenditure.

1. View Report Details
Cardiac Rhythm Management Market
---------------------------------------------------------
2012

2. View Report Details
Executive Summary
Cardiac rhythm management (CRM) is a well established segment of the cardiology devices market. CRM devices are commonly used for
the treatment of arrhythmias and heart failure. Factors like market demand, innovative products, government regulations and
reimbursement policies influence the CRM market. The market is facing slowdown in sales but with the technological advancements such
as introduction of MRI pacemakers, subcutaneous ICDs, and home automated external defibrillators (AEDs), the market is expected to
bounce back.
CRM market is mainly bifurcated into two segments viz. Implantable Cardioverter Defibrillators (ICD) market and Implantable Pacemakers
market. For the past several years, pacemakers and ICDs have become a common therapy given to patients who are suffering from
cardiac rhythm abnormalities. ICD segment of the CRM market is the larger segment in comparison with pacemaker. The sales of both the
segments are likely to increase resulting in improvement in the overall Cardiac Rhythm Management market.
The present report offers a comprehensive analysis of the worldwide cardiac rhythm management market. The competition in the global
CRM market is intense with few large players viz. Medtronic, Boston Scientific and St. Jude Medical. The competitive landscape the global
and regional CRM markets, along with the company profiles of the leading players are discussed in detail.
The key trends observed within the industry include shifted focus towards primary prevention. On the development front, there has been
launch of new pacemakers and technological advancements in ICDs. But there are certain challenges which the industry is facing as of
now. The major factors which will contribute in the growth of the industry include growing ageing population since with age people get
more heart diseases, rising obese population, increasing cases of hypertension since high blood pressure is a major risk for heart attack
and rising healthcare expenditure.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the
industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base
to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or
predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.

3. Cardiac rhythm management (CRM) is a field of treatment in cardiology, which primarily manages cardiac
rhythm disorders..
Worldwide CRM Market Sales (Q111-Q412E)
As of the first quarter of 2012, the sales of CRM market
increased from US$..... million in the fourth quarter of 2011
to US$....... million, witnessing a growth of ……%. In the
fourth quarter of 2012, the sales might increase by ……%
reaching to US$...... million in comparison with last quarter of
2012.
US$ Million
The sales of CRM in the US decreased from US$..... million
in the first quarter of 2012 to US$......million in the second
quarter of 2012, reporting a decline of ……%.
The sales of CRM market outside the US declined from
US$...... million in first quarter of 2012 to US$...... million in
second quarter of 2012, reporting a decline of …..%.
•Industry Developments and trends:
Q111 Q211 Q311 Q411 Q112 Q212 Q312E Q412E
-Shift in Focus towards Primary Prevention
- Launch of New Pacemakers
Worldwide CRM Market by Region (Q111-Q412E)
- Technological Advancements in ICDs.
Market Growth Drivers
-Rising Ageing Population
-Rising Obese Population
-Increasing Case of Hypertension
-Rising Healthcare Expenditure
US$ Billion
-Rise in consumption of alcohol and tobacco
Q111 Q211 Q311 Q411 Q112 Q212 Q312E Q412E
The US Outside the US

4. CRM market is bifurcated into two segments viz. Implantable Cardiac Defibrillators (ICD) and Pacemaker
Market..
Global CRM Market by Segments (2012E) In 2012, the ICD market is expected to account for ……% of the total
CRM market, followed by pacemakers which are expected to account
for ……% share of the total CRM market.
 The sales of ICD market witnessed an increase of …..% by rising
from US$..... million in the fourth quarter of 2011 to US$...... million in
the first quarter of 2012. However, sales declined till third quarter to
US$.... million in comparison with the previous quarters. But, this
decline might get rebound in the last quarter of 2012 showing growth of
……%.
 The sales for pacing systems registered an increase from US$......
million in the fourth quarter of 2011 to US$...... million in first quarter of
2012, reporting an improvement of ……%. In 2012, sales of pacing
systems segment increase by ……% in the fourth quarter of 2012 after
declining in second and third quarters of 2012.
ICD Pacemaker
Worldwide Pacing System Market Sales (Q111-Q412E)
Worldwide ICD Market Sales (Q111-Q412E)
US$ Million
US$ Million
Q111 Q211 Q311 Q411 Q112 Q212 Q312E Q412E
Q111 Q211 Q311 Q411 Q112 Q212 Q312E Q412E

5. The Cardiac Rhythm Management Market is highly fragmented and companies face intense
competition. In 2012, the market leader in terms of revenue is expected to be Medtronic.
Global CRM Market Forecast (2011-2015F)
US$ Billion
2011 2012F 2013F 2014F 2015F
On the competition front, Medtronic is expected to be the leading company in the market for cardiac rhythm management market
world over, with approximately ……% of the market share for the year 2012, followed by St. Jude Medical and Boston Scientific with
……% and ….. % respectively.
 The global CRM market is projected to record a value of US$..….. billion by the end of fiscal 2012 as compared to US$...... billion in
2011. The same is forecasted to reach US$...... billion by 2015, growing at a CAGR of approximately ……% during 2011 to 2015.
Key Issues faced by the respective industry include:
Inappropriate use and malfunctioning of CRM devices.
Note: Market attractiveness is inverse of penetration. Low penetration means high attractiveness and vice-versa

6. Table of Contents
List of Graphs & Tables
1. Cardiac Rhythm Management: An Overview
List of Charts
1.1 ICD
1.1.1 Types OF ICDs CRM Market Segment
Basic Pacemaker Functional Diagram
1.2 Pacing Systems Worldwide CRM Market Sales and Growth (Q111-Q412E)
1.2.1 Types of Pacemakers Worldwide CRM Market by Region (Q111-Q412E)
Global CRM Market by Segment (2012E)
2. Cardiac Rhythm Management Market Worldwide ICD Market Sales and Growth (Q111-Q412E)
The US ICD Market Sales and Growth (Q111-Q412E)
2.1 Global Market Size Outside the US ICD Market Sales and Growth (Q111-Q412E)
Worldwide Pacing System Market Sales and Growth Rate (Q111-
2.2 CRM Market by Region
Q412E)
The US Pacing System Market Sales and Growth Rate (Q111-Q412E)
3. CRM Market by Segments
Outside the US Pacing System Market Sales and Growth Rate (Q111-
Q412E)
3.1 Implantable Cardiac Defibrillators (ICD) Market Worldwide Elderly Population (above 60 years of age) (2007-2012E)
-Worldwide Market Growth in Worldwide Obese Population (2004-2012F)
-US Market BP Pattern across various Stages of Hypertension
-Outside US Market Hypertension Prevalence in the US (2010-2015E)
Hypertension Prevalence in the Developed Europe (2010-2015E)
3.2 Pacing Systems Market Healthcare Expenditure Worldwide (2005-2012E)
-Worldwide Market Global CRM Share by Major Companies (2012E)
-US Market Global ICD Market Share (2012E)
-Outside US Market Global Pacemaker Market Share (2012E)
CRM Market Share in the US (2012E)
ICD Market Share in the US (2012E)
4. Market Dynamics Pacemaker Market Share in the US (2012E)
CRM Market Share outside the US (2012E)
4.1 Growth Drivers ICD Market Share outside the US (2012E)
Pacemaker Market Share outside the US (2012E)
4.1.1 Rising Ageing Population Medtronic Sales by Product Categories (2012)
4.1.2 Rising Obese Population Medtronic Sales by Region (2012)
4.1.3 Increasing Cases of Hypertension Medtronic’s Total Sales and Net Income (2008-2012)
4.1.4 Rising Healthcare Expenditure
4.1.5 Rise in Consumption of Alcohol and Tobacco

7. 4.2 Key Trends
Boston Scientific Sales by Product Categories (2011)
Boston Scientific Sales by Region (2011)
4.2.1 Shifted Focus towards Primary Prevention
Boston Scientifics’ Total Sales and Net Income (2007-2011)
St. Jude Medical Sales by Product Categories (2011)
4.3 Challenges
St. Jude Medical Sales by Region (2011)
4.4 Industry Developments
St. Jude Medical’s Total Sales and Net Income (2007-2011)
Global CRM Market Forecast (2011-2015F)
4.4.1 Launch of New Pacemakers
4.4.2 Technological Advancements in ICDs
List of Tables
5. Competition
-Global CRM Market Share Dependent & Independent Variables (2007-2011)
-Global ICD Market Share Correlation Matrix
-Global Pacemaker Market Share Model Summary – Coefficient of Determination
Regression Coefficients Output
5.1 The US
-CRM Market Share
-ICD Market Share
-Pacemaker Market Share
5.2 Outside the US (International)
-CRM Market Share
-ICD Market Share
-Pacemaker Market Share
6. Company Profiles
6.1 Medtronic
6.1.1 Business Overview
6.1.2 Financial Highlights
6.1.3 Business Strategies
-Expansion through Strategic Acquisitions
-Product Innovation
6.2 Boston Scientific
6.2.1 Business Overview
6.2.2 Financial Highlights

8. 6.2.3 Business Strategies
-Growth through Market Expansion
-Growth through Acquisition Policy
6.3 St. Jude Medical
6.3.1 Business Overview
6.3.2 Financial Highlights
6.3.3 Business Strategies
-Focus on New Product Launches
-Growth through Strategic Acquisitions
7. Market Outlook
7.1 Market Forecast
7.2 Forecast Methodology
7.2.1 Dependent and Independent Variables
7.2.2 Correlation Analysis
7.2.3 Regression Analysis

9. Contact Us:
View Report Details
These are abridged and sanitized sample pages from the comprehensive report on the “Cardiac Rhythm Management Market”.
To know more about this report or for any customized research requirement, please contact the following:
Koncept Analytics
CS-36, Second Floor, Ansal Plaza
Vaishali, Ghaziabad,
U.P. – 201010
Vikas Gupta T. +91-120-4130959
BD Manager C: +91-9811715635
vikas@konceptanalytics.com
www.konceptanalytics.com